An exciting new company driven by seasoned drug hunters is aiming to transform drug discovery with its AI platform for ...

The site, in Stevenage's Town Centre Gardens, was shut in the summer of 2022 due to safety issues with the flooring. The updated £250,000 facility, which will officially reopen on Monday ...

An initial masterplan - described as an "extension to Stevenage" - was rejected by the council last July but the revised proposal was unanimously approved. The land is between Stevenage and ...

The scores are in — the latest batch of food hygiene ratings for Stevenage restaurants, cafés, takeaways and businesses have been revealed. Environmental health officers from Stevenage have ...

Ten small and medium-sized charities have been named as winners of the 2025 GSK IMPACT Awards for their exceptional work improving health and wellbeing. This year’s awards were announced amid a ...

GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its plans to create a six-month regimen are shaping up. ViiV, which is ...

GSK aims to expand its Stevenage facility to create one of the largest life sciences sites in Europe. The future of the giant drug maker is at stake as its boss faces one of her biggest challenges.

Birmingham City will look to extend their lead at the top of League One as the prepare to face midtable Stevenage on Tuesday (March 11) in their game in hand over chasers Wycombe and Wrexham.

It does not necessarily reflect the view of The Herald. The £1 billion regeneration of Stevenage is in full swing, with a number of projects completed or under way, and more planned for the future.

Birmingham City are looking to continue their wonderful home form in League One against Stevenage this evening. Blues recorded their seventh successive home league win on Saturday by beating ...

Writing assistance was provided by Alexus Rivas-John, PharmD, and Eithne Maguire, PhD, CMPP, of Fishawack Indicia Ltd, part of Avalere Health, funded by GSK. FG has served as an advisor for Janssen, ...

GSK Pushes First-in-Class Antibiotic for Uncomplicated UTI By March 26, the FDA is scheduled to release its verdict on GSK’s investigational antibiotic gepotidacin for the treatment of uncomplicated ...